Johnson JNJ Crushes Q1 2026 Estimates EPS 270 Tops Views Lantern Pharma LTRN Q1 2026 Earnings EPS 030 Beats Estimates Red Light Therapy Gains Traction as the Wellness Industrys Next Growth Frontier Republican Primary Victory Strengthens Trumps Grip Policy and Market Implications Assessed